Driving and Implantable Cardioverter-Defibrillator Shocks for Ventricular Arrhythmias

Chen, Albert; Rosenthal, Lawrence; Calkins, Hugh; Steinberg, Jonathan S.; Ruskin, Jeremy N.; Wang, Paul; Muller, James E.; Mittleman, Murray A.; Investigators, Tova

doi:10.1016/j.jacc.2007.06.059

Cited by 55 publications

(34 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Peters et al (2004) found a significant association between people having a first MI and being in traffic (car, bicycle, mass transit) an hour before the MI. Similarly, Albert et al (2007) found large associations for having an implantable cardoverter-defibrillator (ICD) shock, specific to ventricular tachycardia or ventricular fibrillation, with driving an hour previously. Both these findings add coherence to other studies finding adverse CVD morbidity or mortality effects associated with vehicular emissions.…”

Section: Health Effects Of Bc Using Epa Criteria For Judging Potentiamentioning

confidence: 99%

Public health and components of particulate matter: The changing assessment of black carbon

Grahame

Klemm

Schlesinger

2014

Journal of the Air & Waste Management Association

257

157

View full text Add to dashboard Cite

In 2012, the WHO classified diesel emissions as carcinogenic, and its European branch suggested creating a public health standard for airborne black carbon (BC). In 2011, EU researchers found that life expectancy could be extended four to nine times by reducing a unit of BC, vs reducing a unit of PM 2.5. Only recently could such determinations be made. Steady improvements in research methodologies now enable such judgments.In this Critical Review, we survey epidemiological and toxicological literature regarding carbonaceous combustion emissions, as research methodologies improved over time. Initially, we focus on studies of BC, diesel, and traffic emissions in the Western countries (where daily urban BC emissions are mainly from diesels). We examine effects of other carbonaceous emissions, e.g., residential burning of biomass and coal without controls, mainly in developing countries.Throughout the 1990s, air pollution epidemiology studies rarely included species not routinely monitored. As additional PM 2.5. chemical species, including carbonaceous species, became more widely available after 1999, they were gradually included in epidemiological studies. Pollutant species concentrations which more accurately reflected subject exposure also improved models.Natural "interventions" -reductions in emissions concurrent with fuel changes or increased combustion efficiency; introduction of ventilation in highway tunnels; implementation of electronic toll payment systems -demonstrated health benefits of reducing specific carbon emissions. Toxicology studies provided plausible biological mechanisms by which different PM species, e.g., carbonaceous species, may cause harm, aiding interpretation of epidemiological studies.Our review finds that BC from various sources appears to be causally involved in all-cause, lung cancer, and cardiovascular mortality, morbidity, and perhaps adverse birth and nervous system effects. We recommend that the U.S. EPA rubric for judging possible causality of PM 2.5. mass concentrations, be used to assess which PM 2.5. species are most harmful to public health. Implications: Black carbon (BC) and correlated co-emissions appear causally related with all-cause, cardiovascular, and lung cancer mortality, and perhaps with adverse birth outcomes and central nervous system effects. Such findings are recent, since widespread monitoring for BC is also recent. Helpful epidemiological advances (using many health relevant PM 2.5 species in models; using better measurements of subject exposure) have also occurred. "Natural intervention" studies also demonstrate harm from partly combusted carbonaceous emissions. Toxicology studies consistently find biological mechanisms explaining how such emissions can cause these adverse outcomes. A consistent mechanism for judging causality for different PM 2.5 species is suggested.A list of acronyms will be found at the end of the article. Aims of Critical ReviewThis critical review (CR) consists of three main sections. First, we review recent major regulatory and scien...

show abstract

Section: Health Effects Of Bc Using Epa Criteria For Judging Potentiamentioning

confidence: 99%

Public health and components of particulate matter: The changing assessment of black carbon

Grahame

Klemm

Schlesinger

2014

Journal of the Air & Waste Management Association

257

157

View full text Add to dashboard Cite

show abstract

“…Risk depends somewhat on specific underlying cardiac arrhythmias. 8 Moreover, the TOVA trial 16 examined the risk of implantable cardioverter-defibrillator (ICD) shocks for VT or ventricular fibrillation (VF) associated with driving. Although the risk of ICD shock for VT/VF was transiently increased in the 30-minute period after driving, the risk was not elevated during driving and the absolute risk was low.…”

Section: Pathophysiologic Features Of Syncope and Drivingmentioning

confidence: 99%

Syncope and Driving

Guzmán

Morillo

2015

Cardiology Clinics

View full text Add to dashboard Cite

“…As the driving restrictions can make the life situation of the patient and their families more difficult, this may affect adherence to the recommendations. Several studies [52][53][54][55][56][57][58][59][60] point in the direction of low adherence among recipients to the driving ban advised by healthcare professionals. In an early report, despite medical advice never to drive again, Finch et al [45] indicated that 70% resumed driving, with the majority doing so by 8 months after ICD implantation.…”

Section: Psychosocial Adherence and Ethical Issues Of Driving Restrmentioning

confidence: 99%

Consensus Statement: Consensus Statement of the European Heart Rhythm Association: Updated Recommendations for Driving by Patients with Implantable Cardioverter Defibrillators

Vijgen

Botto

Camm

et al. 2010

European Journal of Cardiovascular Nursing

View full text Add to dashboard Cite

Patients with an implantable cardioverter defibrillator (ICD) have an ongoing risk of sudden incapacitation that might cause harm to others while driving a car. Driving restrictions vary across different countries in Europe. The most recent recommendations for driving of ICD patients in Europe were published in 1997 and focused mainly on patients implanted for secondary prevention. In recent years there has been a vast increase in the number of patients with an ICD and in the percentage of patients implanted for primary prevention. The EHRA task force on ICD and driving was formed to reassess the risk of driving for ICD patients based on the literature available. The recommendations are summarized in the following table and are further explained in the document, (Table see text). Driving restrictions are perceived as difficult for patients and their families, and have an immediate consequence for their lifestyle. To increase the adherence to the driving restrictions, adequate discharge of education and follow-up of patients and family are pivotal. The task force members hope this document may serve as an instrument for European and national regulatory authorities to formulate uniform driving regulations.

show abstract

Driving and Implantable Cardioverter-Defibrillator Shocks for Ventricular Arrhythmias

Cited by 55 publications

References 28 publications

Public health and components of particulate matter: The changing assessment of black carbon

Public health and components of particulate matter: The changing assessment of black carbon

Syncope and Driving

Consensus Statement: Consensus Statement of the European Heart Rhythm Association: Updated Recommendations for Driving by Patients with Implantable Cardioverter Defibrillators

Contact Info

Product

Resources

About